Article info

Download PDFPDF
Exposure to acid-suppressing medications in the first 6 months of life is associated with an increased risk of allergic disease diagnosis

Authors

  1. Correspondence to Dr Rebecca Amy Dalrymple, Acorn Center, Vale of Leven District General Hospital, Alexandria G83 0UA, UK; rebecca.dicks{at}doctors.org.uk
View Full Text

Citation

Dalrymple RA
Exposure to acid-suppressing medications in the first 6 months of life is associated with an increased risk of allergic disease diagnosis

Publication history

  • First published November 21, 2018.
Online issue publication 
May 17, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.